Company news
Ironwood Pharmaceuticals, Inc. news in 2023
Ironwood Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
December 11, 2023
Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
November 8, 2023
Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call
October 25, 2023
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
October 22, 2023
Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week
October 15, 2023
Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old
October 4, 2023
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
August 7, 2023
Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call
July 24, 2023
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
June 28, 2023
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
June 15, 2023
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
June 11, 2023
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
May 21, 2023
Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference
May 8, 2023
Ironwood Presents New Data on Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old at Digestive Disease Week® 2023
May 7, 2023
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
May 3, 2023
Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old
April 23, 2023
Ironwood Pharmaceuticals to Host First Quarter 2023 Investor Update Call
April 19, 2023
Ironwood Pharmaceuticals to Participate in Upcoming Investor Conferences
February 26, 2023
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
February 15, 2023
Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of Supplemental New Drug Application for LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old
February 12, 2023
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2022 Investor Update Call
February 1, 2023
Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance
January 8, 2023
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 3, 2023
Calls in 2023
- Ironwood Pharmaceuticals (NASDAQ:IRWD) Q3 2023 Earnings Call
Nov 9, 2023
Transcript - Ironwood Pharmaceuticals (NASDAQ:IRWD) Q2 2023 Earnings Call
Aug 8, 2023
Transcript - Ironwood Pharmaceuticals (NASDAQ:IRWD) Q1 2023 Earnings Call
May 4, 2023
Transcript - Ironwood Pharmaceuticals (NASDAQ:IRWD) Q4 2022 Earnings Call
Feb 16, 2023
Transcript
Decks in 2023
- Q3 2023 Earnings Presentation
Earnings · 22 slides · Nov 9, 2023
- Q2 2023 Earnings Presentation
Earnings · 16 slides · Aug 8, 2023
- Merger or Acquisition (May 2023)
Merger or acquisition · 17 slides · May 22, 2023
- Q1 2023 Earnings Presentation
Earnings · 16 slides · May 4, 2023
- FY2022 Earnings Presentation
Earnings · 16 slides · Feb 16, 2023
- 41st Annual J.P. Morgan Healthcare Conference (January 2023)
Conference · 26 slides · Jan 11, 2023